Baumeister, Julian
Chatain, Nicolas http://orcid.org/0000-0003-4485-3120
Hubrich, Annika
Maié, Tiago
Costa, Ivan G. http://orcid.org/0000-0003-2890-8697
Denecke, Bernd
Han, Lijuan
Küstermann, Caroline
Sontag, Stephanie
Seré, Kristin
Strathmann, Klaus
Zenke, Martin
Schuppert, Andreas
Brümmendorf, Tim H.
Kranc, Kamil R.
Koschmieder, Steffen http://orcid.org/0000-0002-1011-8171
Gezer, Deniz
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KO2155/6-1)
START grant, Faculty of Medicine, RWTH Aachen
Article History
Received: 17 June 2019
Revised: 17 October 2019
Accepted: 3 November 2019
First Online: 14 November 2019
Compliance with ethical standards
:
: SK reports advisory board activity for Pfizer, Incyte/Ariad, Novartis, AOP Pharma, BMS, CTI, Roche, Baxalta, Sanofi, honoraria from Novartis, BMS, Pfizer, Incyte/Ariad, Shire, Roche, AOP Pharma, Janssen, research funding from Novartis Foundation, BMS, Novartis, and other financial disclosures (i.e., travel support) from Alexion, Novartis, BMS, Incyte/Ariad, AOP Pharma, Baxalta, CTI, Pfizer, Sanofi, Celgene, Shire, and Janssen. THB reports consultancy from Pfizer, Novartis, Janssen, Merck, Incyte/Ariad and research funding from Pfizer and Novartis. DG reports advisory board activity for AMGEN. The remaining authors declare that they have no conflict of interest.